YAP in Kupffer cells enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis.
Yes-associated protein (YAP) plays an important role in hepatocarcinogenesis, although the potential role of YAP in non-neoplastic liver diseases remains largely unknown. We report herein that YAP in Kupffer cells (KCs) enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis. Our data show that the expression of YAP is significantly increased in KCs of wild type mice fed HFD. We then generated mice with macrophage/monocyte-specific deletion of YAP (YAPϕKO ) or TLR4 (TLR4ϕKO ) and the animals were fed high fat diet (HFD) or treated with LPS. Our data showed that YAPϕKO mice fed HFD exhibited lower serum ALT/AST levels and less hepatic inflammation when compared to their littermate controls. LPS treatment induced the accumulation of YAP in KCs in vitro and in mice which was prevented by macrophage/monocyte-specific deletion of TLR4 (TLR4ϕKO ). LPS transcriptionally activates YAP via AP-1 in macrophages/KCs. The LPS-induced YAP further enhances the expression of pro-inflammatory cytokines (including MCP-1, TNF-α and IL-6) through YAP association with the TEAD-binding motif in the promoter region of inflammatory cytokines. Forced overexpression of active YAP (YAP5SA) in KCs enhanced the production of pro-inflammatory cytokines. Treatment of HFD-fed mice with verteporfin inhibited Kupffer cell activation, reduced liver inflammation and decreased serum ALT/AST levels. Analyses of liver tissues from NASH patients reveal that YAP is increased in KCs and that the level of YAP in human liver tissues is positively correlated with the expression of pro-inflammatory cytokines. Conclusions: This study describes an important role of YAP in Kupffer cells for regulation of liver inflammation in NASH. Our findings suggest that inhibition of YAP may represent a novel and effective therapeutic strategy for NASH treatment.